Varenicline Tartrate(CAS: 375815-87-5)

Varenicline Tartrate (CAS: 375815-87-5) is a pharmaceutical compound used primarily in smoking cessation treatments. It acts as a partial agonist at nicotinic acetylcholine receptors, helping to reduce nicotine cravings and withdrawal symptoms. Its chemical formula is C14H15NO3·C4H6O6, and it is a white to off-white powder with good solubility in water and alcohol.

Varenicline Tartrate (CAS: 375815-87-5) is mainly used in pharmaceuticals for smoking cessation therapy. It is also employed in research for studying nicotinic receptor interactions and in drug development for nicotine addiction treatments. Its applications include aiding patients in quitting smoking and supporting clinical studies on nicotine dependence.

Varenicline Tartrate (CAS: 375815-87-5) is generally considered safe when used as directed in medical settings. However, it can cause side effects such as nausea, headache, and sleep disturbances. Proper handling and adherence to safety guidelines are essential, especially during storage and transportation. It is regulated by health authorities and must be used under professional supervision.

Varenicline Tartrate (CAS: 375815-87-5) should be stored in a cool, dry place away from direct light. It is typically kept at a temperature between 15°C to 25°C (59°F to 77°F) and in airtight containers to prevent moisture exposure. Proper storage ensures the stability and efficacy of the compound over time.